Analyst consensus rating
Calumet Analyst Rating: Buy
CLMT is rated Buy by 5 analysts with a $43.20 target. As of 2026-08-20.
Direct answer
Calumet's consensus rating is Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $43.20.
Forecast evidence checked August 20, 2026.
Get free Calumet email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $48.71
- Average price target
- $43.20
- High price target
- $60.00
- Low price target
- $26.00
- Low target gap
- -46.6%
- Target upside
- -11.3%
- High target gap
- +23.2%
- Target range width
- 69.8%
- Consensus rating
- Buy
- Analysts
- 5
- Evidence date
- August 20, 2026
- Valid through
- August 27, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Calumet?
Calumet has a verified Buy consensus. The same dataset has an average price target of $43.20.
How far are Calumet's low and high targets from the recorded price?
The low target implies -46.6%, while the high target implies +23.2%.
How many analysts are included in Calumet's consensus?
The verified consensus includes 5 analysts.
How is Calumet's target upside or downside calculated?
The average target of $43.20 is divided by the recorded price of $48.71, then one is subtracted to produce -11.3%. This does not guarantee a future return.
When was Calumet's analyst forecast verified?
The data was verified on 2026-08-20. The dataset is valid through 2026-08-27.